DIPNA PHARMACHEM LIMITED: Detailed financials
Line items extracted directly from the company's exchange-filed XBRL. Click + to expand subtotals. Click any row to chart it. Monetary values are in ₹ crore.
Company financials
| Particulars | Mar-23 | Mar-24 | Mar-25 | Mar-26 |
|---|---|---|---|---|
| 51 | 90 | 34 | 2 | |
| 0.01 | −0.15 | 0.01 | 0.03 | |
| — | — | — | 2 | |
| 50 | 90 | 33 | 2 | |
| 52 | 96 | 28 | 14 | |
| −3 | −9 | −1 | −15 | |
| 0.25 | 0.22 | 0.22 | 0.10 | |
| 0.51 | 1 | 1 | 0.23 | |
| 0.64 | 2 | 6 | 3 | |
| 1 | 2 | 2 | 0.45 | |
| 1 | 2 | 2 | 0.45 | |
| — | — | — | 0.22 | |
| 0.93 | 0.62 | 0.97 | 0.22 | |
| 0.35 | 0.13 | 0.33 | 0.04 | |
| 0.58 | 0.49 | 0.64 | 0.18 | |
| Financial ratios | ||||
| 2.81% | 1.94% | 5.75% | 22.28% | |
| 1.13% | 0.54% | 1.87% | 8.91% | |
| 0.48 | 0.41 | 0.27 | 0.07 | |
Revenue
₹ crore
Select any table row to compare its reported history.
Source: official NSE or BSE financial-result filings & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Derived margins, subtotals, leverage and cash-flow measures use only the displayed filed line items.